In This Issue

Accreditation Statistics

As of October 1, 2023

Cellular Therapy Entities

  • Accredited: 258
  • Applicants: 26

Cord Blood Banks

  • Accredited: 53
  • Applicants: 9

Congratulations to the following programs for achieving initial FACT accreditation:

  • Kingston Health Sciences Centre
  • CTCA-COH Arizona Hematologic Malignancy and Cellular Therapy Institute (CAHCTI)
  • The Good Samaritan Hospital of Cincinnati, Ohio

A complete list of accredited organizations can be found at www.factglobal.org.

FACT’s IEC Webinar Series Continues in January 2023

Posted in :: 2022 Volume 6 :: Tuesday, December 20th, 2022

Quality Immune Effector Cellular Therapy for the Treatment of Solid Tumors Webinar:
Tumor Infiltrating Lymphocytes

Tuesday, January 17, 2023, | 11:00 am ET

Tumor-infiltrating lymphocytes (TILs) can recognize and kill cancer cells. This webinar will provide a broad introduction to TILs and a review of current clinical experience and unique considerations in TIL manufacturing. Presenters will also discuss the need for establishing safety and efficacy quality benchmarks for TILs.

Register Now!

Quality Immune Effector Cellular Therapy for the Treatment of Solid Tumors Webinar:
CAR-T cells and T-cell Receptor Cells in Solid Tumors

Thursday, March 30, 2023, | 11:00 am ET

CAR-T and TCR cell therapy has demonstrated encouraging potential for the treatment of solid tumors. During this webinar, presenters will highlight current clinical experience with CAR-T cells in solid tumors and unique considerations in manufacturing. Presenters will also discuss the need for establishing safety and efficacy quality benchmarks for CAR-T cells and TCRs.

Register Now!